These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8288162)

  • 1. Lipoprotein (a) in thyroid dysfunction before and after treatment.
    Spandrio S; Sleiman I; Scalvini T; Salvi A; Di Stefano O; Pagliaini R; Balestrieri GP
    Horm Metab Res; 1993 Nov; 25(11):586-9. PubMed ID: 8288162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein (a) levels in thyroid dysfunction before and after treatment.
    Sucić M; Bozikov V; Mesić R; Sokolić L
    Croat Med J; 1998 Mar; 39(1):19-22. PubMed ID: 9475802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of thyroid status on serum apolipoprotein A-I-containing lipoprotein particles.
    Ozata M; Yildirimkaya M; Yilmaz K; Kutluay T; Corakci A; Beyhan Z; Gundogan MA
    Horm Metab Res; 1998 Apr; 30(4):217-21. PubMed ID: 9623637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.
    Nishitani H; Okamura K; Noguchi S; Inoue K; Morotomi Y; Fujishima M
    Horm Metab Res; 1990 Sep; 22(9):490-3. PubMed ID: 2258137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Apr; 54(2):77-81. PubMed ID: 10378018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do increased lipoprotein(a) levels in euthyroid autoimmune thyroid diseases predict an increased risk of arteriosclerosis?].
    Buchinger W; Pongratz R; Binter G; Eber O
    Acta Med Austriaca; 1995; 22(4):78-1. PubMed ID: 8835427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein (a) studies in thyroid diseases].
    Boda J; Paragh G; Szabó J; Mezösi E; Nagy E
    Orv Hetil; 1997 Sep; 138(36 Suppl 2):2307-9. PubMed ID: 9340577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
    Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
    Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aspirin on lipoprotein(a) in patients with ischemic stroke.
    Ranga GS; Kalra OP; Tandon H; Gambhir JK; Mehrotra G
    J Stroke Cerebrovasc Dis; 2007; 16(5):220-4. PubMed ID: 17845920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.
    de Bruin TW; van Barlingen H; van Linde-Sibenius Trip M; van Vuurst de Vries AR; Akveld MJ; Erkelens DW
    J Clin Endocrinol Metab; 1993 Jan; 76(1):121-6. PubMed ID: 8421075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
    Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
    Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
    Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men.
    Berg G; Schreier L; Geloso G; Otero P; Nagelberg A; Levalle O
    Horm Metab Res; 2002 Feb; 34(2):87-92. PubMed ID: 11972293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
    Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.